• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510400
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Swelling (2091); Weakness (2145); Ambulation Difficulties (2544)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.
 
Event Description
It was reported that on (b)(6) 2004, the patient underwent lumbar fusion at levels l4-5 wherein rhbmp-2/acs was implanted.Post-op, the patient had increasing low back pain, and associated radiculopathy in his lower extremities.The patient continued to experience constant and extreme lower back pain, radiating pain to his hips, groin and legs, weakness in his legs, and swelling in his feet.He was unable to sit or stand for extended periods and has difficult walking.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that on (b)(6) 2004, the patient was pre-operatively diagnosed with pseudoarthrosis at l4-5 and underwent the following procedure: l4-5 complete diskectomy with removal of cages and osteotomy of take down of pseudoarthrosis.L4-5 anterior lumbar interbody fusion.Insertion of spacer with rhbmp-2 soaked collagen sponges at l4-5.L4-5 anterior plating.Anterior retroperitoneal exposure of the l4-l5 with mobilization of the iliac vessels, the aorta and vena cava, and also the peritoneal tear.Diskectomy and removal of previously implanted cages (two).Application of femoral bone graft with rhbmp-2 at l4-l5.Fixation of l4-l5 with plate and screws.As per the op notes:¿ the spacer was packed full of rhbmp-2 soaked collagen sponges and then seated in the resection gap under c-arm guidance.The distractor was removed under c-arm guidance.The anterior lumbar plate was applied across the l4-5 interval using 24 mm depth screws.All screws were tightened down so they engaged the locking mechanism on the plate.¿ the patient tolerated the procedure without any intraoperative complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key5554823
MDR Text Key42076747
Report Number1030489-2016-01002
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup
Report Date 12/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number7510400
Device Lot NumberM112003ABF
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/10/2016
Initial Date FDA Received04/07/2016
Supplement Dates Manufacturer Received03/10/2016
11/06/2017
Supplement Dates FDA Received09/20/2017
12/01/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-